Search

Search Constraints

You searched for: Author/Creator Kallen, Joerg

Search Results

1. Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface. (23rd October 2018)

2. Corrigendum to "Tetra-substituted imidazoles as a new class of inhibitors of the p53–MDM2 interaction" [Bioorg. Med. Chem. Lett. 24 (9) (2014) 2110–2114]. Issue 6 (15th March 2015)

3. Corrigendum to "Tetra-substituted imidazoles as a new class of inhibitors of the p53–MDM2 interaction" [Bioorg. Med. Chem. Lett. 24 (9) (2014) 2110–2114]. Issue 6 (15th March 2015)

4. Cover Picture: Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor Antagonist (ChemMedChem 3/2017). (3rd February 2017)

5. Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor Antagonist. (15th November 2016)

6. Discovery of a novel class of highly potent inhibitors of the p53–MDM2 interaction by structure-based design starting from a conformational argument. Issue 19 (1st October 2016)

7. Discovery of dihydroisoquinolinone derivatives as novel inhibitors of the p53–MDM2 interaction with a distinct binding mode. Issue 17 (1st September 2015)

8. Discovery, X-ray structure and CPP-conjugation enabled uptake of p53/MDM2 macrocyclic peptide inhibitors. Issue 6 (16th September 2021)

9. Effect of the acylation of TEAD4 on its interaction with co‐activators YAP and TAZ. (11th November 2017)

10. Front Cover: Structural States of Hdm2 and HdmX: X‐ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes (ChemMedChem 14/2019). (17th July 2019)